Realizing the Future that Regenerative Medicine Will Open

Regenerative medicine opens up the possibility of providing previously unavailable new treatments such as using processed cells for overcoming previously untreatable diseases and for reconstructing tissues. By providing cures for patients, it can also help reduce medical costs and health insurance premiums by eliminating the need for long-term hospitalization or drug regimes. It is being forecast that the market for regenerative medicine will grow rapidly from 2020 onwards as increasing clinical use is made of induced pluripotent stem (iPS) or embryonic stem cells, reaching a predicted market size of 17 trillion yen globally by 2030, including the associated industries. Currently still in its infancy, one of the most important issues currently facing regenerative medicine is the research and development of therapeutically effective cells. Precise and efficient culturing techniques for getting cells to differentiate into the desired cell type based on basic findings are actively INTRODUCTION